{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T12:05:53Z","timestamp":1791201953437,"version":"4.2.0"},"reference-count":45,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1016\/j.thromres.2011.04.009","type":"journal-article","created":{"date-parts":[[2011,5,11]],"date-time":"2011-05-11T06:26:11Z","timestamp":1305095171000},"page":"570-576","source":"Crossref","is-referenced-by-count":31,"title":["Recombinant factor VIIa analog NN1731 (V158D\/E296V\/M298Q-FVIIa) enhances fibrin formation, structure and stability in lipidated hemophilic plasma"],"prefix":"10.1016","volume":"128","author":[{"given":"Laura D.","family":"Gray","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A.","family":"Hussey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brittany M.","family":"Larson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kellie R.","family":"Machlus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary","family":"Koch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirella","family":"Ezban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulla","family":"Hedner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alisa S.","family":"Wolberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.thromres.2011.04.009_bb0005","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1097\/MOH.0b013e3280dce57b","article-title":"Recombinant factor VIIa: its background, development and clinical use","volume":"14","author":"Hedner","year":"2007","journal-title":"Curr Opin Hematol"},{"key":"10.1016\/j.thromres.2011.04.009_bb0010","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1046\/j.1365-2141.1997.4463256.x","article-title":"Platelet activity of high-dose factor VIIa is independent of tissue factor","volume":"99","author":"Monroe","year":"1997","journal-title":"Br J Haematol"},{"key":"10.1016\/j.thromres.2011.04.009_bb0015","first-page":"S15","article-title":"A possible mechanism of action of activated factor VII independent of tissue factor","volume":"9","author":"Monroe","year":"1998","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.thromres.2011.04.009_bb0020","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1111\/j.1365-2141.2005.05820.x","article-title":"High dose factor VIIa enhances clot stability in a model of hemophilia B","volume":"131","author":"Wolberg","year":"2005","journal-title":"Br J Haematol"},{"key":"10.1016\/j.thromres.2011.04.009_bb0025","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1161\/01.ATV.0000257204.82396.2b","article-title":"A variant of recombinant factor VIIa with enhanced procoagulant and antifibrinolytic activities in an in vitro model of hemophilia","volume":"27","author":"Allen","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.thromres.2011.04.009_bb0030","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1046\/j.1538-7836.2003.00242.x","article-title":"The role of recombinant factor VIIa (FVIIa) in fibrin structure in the absence of FVIII\/FIX","volume":"1","author":"He","year":"2003","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.thromres.2011.04.009_bb0035","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1046\/j.1538-7836.2003.00059.x","article-title":"A new approach to treatment of bleeding episodes in young hemophilia patients: a single bolus megadose of recombinant activated factor VII (NovoSeven)","volume":"1","author":"Kenet","year":"2003","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.thromres.2011.04.009_bb0040","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1046\/j.1365-2516.2001.00553.x","article-title":"Rationale for the use of high dose rFVIIa in a high-titre inhibitor patient with haemophilia B during major orthopaedic procedures","volume":"7","author":"Cooper","year":"2001","journal-title":"Haemophilia"},{"key":"10.1016\/j.thromres.2011.04.009_bb0045","doi-asserted-by":"crossref","first-page":"13583","DOI":"10.1073\/pnas.241339498","article-title":"Rational design of coagulation factor VIIa variants with substantially increased intrinsic activity","volume":"98","author":"Persson","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.thromres.2011.04.009_bb0050","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1046\/j.1538-7836.2003.00444.x","article-title":"Enhanced in vitro procoagulant and antifibrinolytic potential of superactive variants of recombinant factor VIIa in severe hemophilia A","volume":"1","author":"Lisman","year":"2003","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.thromres.2011.04.009_bb0055","doi-asserted-by":"crossref","first-page":"3615","DOI":"10.1182\/blood-2003-05-1369","article-title":"Improved hemostasis with superactive analogs of factor VIIa in a mouse model of hemophilia A","volume":"102","author":"Tranholm","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2011.04.009_bb0060","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1111\/j.1538-7836.2009.03532.x","article-title":"Faster onset of effect and greater efficacy of NN1731 compared with rFVIIa, aPCC and FVIII in tail bleeding in hemophilic mice","volume":"7","author":"Holmberg","year":"2009","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.thromres.2011.04.009_bb0065","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/j.1538-7836.2008.03253.x","article-title":"Evaluation of the safety and pharmacokinetics of a fast-acting recombinant FVIIa analogue, NN1731, in healthy male subjects","volume":"7","author":"Moss","year":"2009","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.thromres.2011.04.009_bb0070","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1182\/blood.V116.21.719.719","article-title":"Safety and preliminary efficacy of recombinant activated FVII analog (NN1731) In the treatment of joint bleeds In congenital hemophilia patients with inhibitors","volume":"116","author":"de Paula","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2011.04.009_bb0075","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1161\/ATVBAHA.108.176008","article-title":"Cellular procoagulant activities dictate clot structure and stability as a function of distance from the cell surface","volume":"28","author":"Campbell","year":"2008","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.thromres.2011.04.009_bb0080","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0005-2736(85)90521-8","article-title":"Production of large unilamellar vesicles by a rapid extrusion procedure. Characterization of size distribution, trapped volume and ability to maintain a membrane potential","volume":"812","author":"Hope","year":"1985","journal-title":"Biochem Biophys Acta"},{"key":"10.1016\/j.thromres.2011.04.009_bb0085","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1160\/TH09-03-0180","article-title":"Effect of tissue factor, thrombomodulin, and elevated clotting factor levels on thrombin generation in the calibrated automated thrombogram","volume":"102","author":"Machlus","year":"2009","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.thromres.2011.04.009_bb0090","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1182\/blood.V100.2.539","article-title":"Activated protein C cleaves factor Va more efficiently on endothelium than on platelet surfaces","volume":"100","author":"Oliver","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2011.04.009_bb0095","doi-asserted-by":"crossref","DOI":"10.2307\/2683354","article-title":"On Fieller's theorem and the general linear model","volume":"32","author":"Zerbe","year":"1978","journal-title":"The American Statistician"},{"key":"10.1016\/j.thromres.2011.04.009_bb0100","series-title":"Categorical data analysis using the SAS system","author":"Stokes","year":"2000"},{"key":"10.1016\/j.thromres.2011.04.009_bb0105","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1161\/01.ATV.0000042081.57854.A2","article-title":"Influence of factor VIIa and phospholipids on coagulation in \"acquired\" hemophilia.[comment]","volume":"23","author":"Butenas","year":"2003","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.thromres.2011.04.009_bb0110","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1111\/j.1538-7836.2005.01683.x","article-title":"Prerequisites for recombinant factor VIIa-induced thrombin generation in plasmas deficient in factors VIII, IX or XI","volume":"4","author":"Livnat","year":"2006","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.thromres.2011.04.009_bb0115","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1160\/TH06-11-0664","article-title":"Haemophilia patients exhibit prolonged coagulation time but normal lag time of thrombin generation test: are these results really discordant?","volume":"97","author":"Dargaud","year":"2007","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.thromres.2011.04.009_bb0120","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.blre.2006.11.001","article-title":"Thrombin generation and fibrin clot structure","volume":"21","author":"Wolberg","year":"2007","journal-title":"Blood Rev"},{"key":"10.1016\/j.thromres.2011.04.009_bb0125","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1160\/TH09-02-0135","article-title":"Fibrin gel structure obtained with a FVIIa analogue with enhanced FX-activating potential in haemophilia","volume":"102","author":"He","year":"2009","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.thromres.2011.04.009_bb0130","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/0167-4838(89)90140-4","article-title":"Native fibrin gel networks observed by 3D microscopy, permeation and turbidity","volume":"997","author":"Blomback","year":"1989","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.thromres.2011.04.009_bb0135","doi-asserted-by":"crossref","first-page":"3824","DOI":"10.1182\/blood-2005-05-2150","article-title":"The alphaC domains of fibrinogen affect the structure of the fibrin clot, its physical properties, and its susceptibility to fibrinolysis","volume":"106","author":"Collet","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2011.04.009_bb0140","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1111\/j.1365-2141.1984.tb06121.x","article-title":"The haemostatic plug in haemophilia A: a morphological study of haemostatic plug formation in bleeding time skin wounds of patients with severe haemophilia A","volume":"58","author":"Sixma","year":"1984","journal-title":"Br J Haematol"},{"key":"10.1016\/j.thromres.2011.04.009_bb0145","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1160\/TH07-08-0525","article-title":"Prolonged in-vivo half-life of factor VIIa by fusion to albumin","volume":"99","author":"Weimer","year":"2008","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.thromres.2011.04.009_bb0150","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1111\/j.1365-2516.2008.01741.x","article-title":"Enhancement of factor VIIa haemostatic efficacy by formulation with PEGylated liposomes","volume":"14","author":"Yatuv","year":"2008","journal-title":"Haemophilia"},{"key":"10.1016\/j.thromres.2011.04.009_bb0155","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1111\/j.1538-7836.2007.02308.x","article-title":"Activity and regulation of glycoPEGylated factor VIIa analogs","volume":"5","author":"Ghosh","year":"2008","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.thromres.2011.04.009_bb0160","doi-asserted-by":"crossref","first-page":"4229","DOI":"10.1073\/pnas.95.8.4229","article-title":"Manipulation of the membrane binding site of vitamin K-dependent proteins: enhanced biological function of human factor VII","volume":"95","author":"Shah","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.thromres.2011.04.009_bb0165","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1042\/bj20031596","article-title":"Augmented intrinsic activity of Factor VIIa by replacement of residues 305, 314, 337 and 374: evidence of two unique mutational mechanisms of activity enhancement","volume":"379","author":"Persson","year":"2004","journal-title":"Biochem J"},{"key":"10.1016\/j.thromres.2011.04.009_bb0170","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1111\/j.1365-2141.2007.06534.x","article-title":"Factor VIIa analogue (V158D\/E296V\/M298Q-FVIIa) normalises clot formation in whole blood from patients with severe haemophilia A","volume":"137","author":"Sorensen","year":"2007","journal-title":"Br J Haematol"},{"key":"10.1016\/j.thromres.2011.04.009_bb0175","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1111\/j.1365-2516.2007.01524.x","article-title":"Effect of recombinant factor VIIa variant (NN1731) on platelet function, clot structure and force onset time in whole blood from healthy volunteers and haemophilia patients","volume":"13","author":"Brophy","year":"2007","journal-title":"Haemophilia"},{"key":"10.1016\/j.thromres.2011.04.009_bb0180","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1111\/j.1538-7836.2007.02308.x","article-title":"Activity and regulation of factor VIIa analogs with increased potency at the endothelial cell surface","volume":"5","author":"Ghosh","year":"2007","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.thromres.2011.04.009_bb0185","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/j.1365-2141.2010.08432.x","article-title":"Intravascular inhibition of factor VIIa and the analogue NN1731 by antithrombin","volume":"152","author":"Petersen","year":"2010","journal-title":"Br J Haematol"},{"key":"10.1016\/j.thromres.2011.04.009_bb0190","first-page":"P-W-113","article-title":"Effect of rFVIIa and NN1731 (RFVIIa analogue) on thromboelastography (TEG) in whole blood obtained from haemophilia A dogs","volume":"5","author":"Viuff","year":"2007","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.thromres.2011.04.009_bb0195","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1053\/j.seminhematol.2003.11.008","article-title":"Dosing with recombinant factor VIIa based on current evidence","volume":"1","author":"Hedner","year":"2004","journal-title":"Semin Hematol"},{"key":"10.1016\/j.thromres.2011.04.009_bb0200","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1159\/000071637","article-title":"Factor VIII inhibitor-bypassing agents act by inducing thrombin generation and can be monitored by a thrombin generation assay","volume":"33","author":"Turecek","year":"2003","journal-title":"Pathophysiol Haemost Thromb"},{"key":"10.1016\/j.thromres.2011.04.009_bb0205","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/0049-3848(89)90268-5","article-title":"Mechanism by which recombinant factor VIIa shortens the aPTT: Activation of factor X in the absence of tissue factor","volume":"56","author":"Telgt","year":"1989","journal-title":"Thromb Res"},{"key":"10.1016\/j.thromres.2011.04.009_bb0210","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1160\/TH08-07-0434","article-title":"Factor VIIa and its potential therapeutic use in bleeding-associated pathologies","volume":"100","author":"Hedner","year":"2008","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.thromres.2011.04.009_bb0215","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1111\/j.1365-2516.2008.01688.x","article-title":"Effects of factor VIII inhibitor bypassing activity (FEIBA), recombinant factor VIIa or both on thrombin generation in normal and haemophilia A plasma","volume":"14","author":"Livnat","year":"2008","journal-title":"Haemophilia"},{"key":"10.1016\/j.thromres.2011.04.009_bb0220","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/0005-2736(83)90169-4","article-title":"Changes in membrane phospholipid distribution during platelet activation","volume":"736","author":"Bevers","year":"1983","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.thromres.2011.04.009_bb0225","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/j.1365-2141.2007.06617.x","article-title":"A novel approach to improving recombinant factor VIIa activity with a preserved platelet preparation","volume":"138","author":"Campbell","year":"2007","journal-title":"Br J Haematol"}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384811001721?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384811001721?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,6,19]],"date-time":"2020-06-19T02:10:35Z","timestamp":1592532635000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384811001721"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12]]},"references-count":45,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["S0049384811001721"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2011.04.009","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2011,12]]}}}